Abstract:The original version of this article unfortunately contained a mistake. For Fig. 1a in p.409, the citation of a reference, as well as the permission to reprint this picture, was missing. The correct version and the corresponding reference are given below: (a) Chest computed tomography (CT) image of Patient 1 on admission presents multiple ground-glass opacities distributed in the periphery of inferior lobe of both lungs. Reprinted from Zhang et al. (2020), with kind permission from Springer Nature.

Erratum: Correction of Figure in the Article "Viral, Immunologic, and Laboratory Parameters in Patients With and Without Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)"

Correction: Corrigendum: Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study

Erratum to: Transmission risk of patients with COVID-19 meeting discharge criteria should be interpreted with caution (Journal of Zhejiang University-SCIENCE B, (2020), 21, 5, (408-410), 10.1631/jzus.B2000117)

Correction to: Postacute Sequelae of COVID (PASC or Long COVID): An Evidenced-Based Approach

Erratum: Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review: Erratum

Erratum To: Transmission Risk of Patients with COVID-19 Meeting Discharge Criteria Should Be Interpreted with Caution

Erratum: Author Correction: Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients

Corrigendum: SARS-CoV-2 evolution among patients with immunosuppression in a nosocomial cluster of a Japanese medical center during the Delta (AY.29 sublineage) surge

Corrigendum: C-reactive protein isoforms as prognostic markers of COVID-19 severity

Correction to Lancet Rheumatol 2020; 2: e557-64

Erratum: "Human lung-on-chips: Advanced systems for respiratory virus models and assessment of immune response" [Biomicrofluidics 15, 021501 (2021)]

Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China

Correction: Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review

Erratum: Asymptomatic Erythematous and Tan, Shiny, Well-Defined Plaques: Erratum

Correction to: Mesenchymal stem cells in the treatment of severe COVID-19

Corrigendum: Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID

Erratum: Approaching hemophagocytic lymphohistiocytosis

Correction to “In-hospital mortality and severe outcomes after hospital discharge due to COVID-19: A prospective multicenter study from Brazil” [Lancet Reg Health Am. 2022 Jul; 11:100244] DOI: 10.1016/j.lana.2022.100244

Corrigendum: Hemorrhagic Fever with Renal Syndrome: Pathogenesis and Clinical Picture

Corrigendum to "Global epidemiology of severe fever with thrombocytopenia syndrome virus in human and animals: a systematic review and meta-analysis" [The Lancet Regional Health - Western Pacific, Volume: 48 (2024) 101133]